The Optimal Anticoagulation for Enhanced Risk Patients Post-Catheter Ablation for Atrial Fibrillation Trial - OCEAN
Atrial FibrillationAtrial fibrillation is an abnormal heart rhythm in which can increase the risk of developing clots in the heart which can then break off and travel to the brain and cause a stroke.
Catheter ablation is a procedure which is used to restore the regular rhythm of the heart; however even when this treatment is successful, patients still may have an increased risk of having a stroke compared to people who have never had atrial fibrillation.
Two types of medication are presently prescribed to patients following their catheter ablation (even if it appears to have been successful in eliminating atrial fibrillation): an antiplatelet (such as aspirin), or an anticoagulant (also known as a blood thinner). This study is being done in order to find out which type of medication works best for preventing strokes in people who have had a successful catheter ablation.
null
Conditions de participation
-
Sexe:
Male, Female, Intersex -
Âges admissibles:
18 to 85
Critères de participation
Inclusion Criteria:
->18 years old
-At least 1 year following successful catheter ablation for AF (Holter monitor reports required)
-Acceptable stroke risk score (determined by physician)
Exclusion Criteria:
-Unable to use blood thinners
-Kidney disease
-Metal heart valve
-Unable to have MRI
-Stroke within 1 year
Lieu de l'étude
Victoria Cardiac Arrhythmia Trials Inc.
Victoria Cardiac Arrhythmia Trials Inc.Victoria, British Columbia
Canada
Contactez l'équipe d'étude
St. Mary's General Hospital
St. Mary's General HospitalKitchener, Ontario
Canada
Contactez l'équipe d'étude
Scarborough Health Network- Rougevalley
Scarborough Health Network- RougevalleyToronto, Ontario
Canada
Contactez l'équipe d'étude
Centre Hospitalier de L'Universite de Montreal (CHUM)
Centre Hospitalier de L'Universite de Montreal (CHUM)Montreal, Quebec
Canada
Contactez l'équipe d'étude
Institut Universitarie de Cardiologie et de Pneumologie de Quebec
Institut Universitarie de Cardiologie et de Pneumologie de QuebecQuébec, Quebec
Canada
Contactez l'équipe d'étude
Royal Columbian/Fraser Clinical Trials
Royal Columbian/Fraser Clinical TrialsNew Westminster, British Columbia
Canada
Contactez l'équipe d'étude
Hamilton Health Sciences Centre
Hamilton Health Sciences CentreHamilton, Ontario
Canada
Contactez l'équipe d'étude
Southlake Regional Health Centre
Southlake Regional Health CentreNewmarket, Ontario
Canada
Contactez l'équipe d'étude
Sunnybrook Health Sciences Centre
Sunnybrook Health Sciences CentreToronto, Ontario
Canada
Contactez l'équipe d'étude
McGill University Health Centre
McGill University Health CentreMontreal, Quebec
Canada
Contactez l'équipe d'étude
St. Paul's Hospital
St. Paul's HospitalVancouver, British Columbia
Canada
Contactez l'équipe d'étude
Kingston General Hospital
Kingston General HospitalKingston, Ontario
Canada
Contactez l'équipe d'étude
University of Ottawa Heart Institute
University of Ottawa Heart InstituteOttawa, Ontario
Canada
Contactez l'équipe d'étude
Sherbrooke- Grandby site
Sherbrooke- Grandby siteGranby, Quebec
Canada
Contactez l'équipe d'étude
Montreal Health Institute
Montreal Health InstituteMontreal, Quebec
Canada
Contactez l'équipe d'étude
Foothills Medical Centre
Foothills Medical CentreCalgary, Alberta
Canada
Contactez l'équipe d'étude
Queen Elizabeth II Health Sciences Centre
Queen Elizabeth II Health Sciences CentreHalifax, Nova Scotia
Canada
Contactez l'équipe d'étude
London Health Sciences Centre
London Health Sciences CentreLondon, Ontario
Canada
Contactez l'équipe d'étude
St. Michael's Hospital
St. Michael's HospitalToronto, Ontario
Canada
Contactez l'équipe d'étude
Hôpital du Sacré-Coeur de Montreal
Hôpital du Sacré-Coeur de MontrealMontreal, Quebec
Canada
Contactez l'équipe d'étude
Centre Hospitalier Universitaire de Sherbrooke
Centre Hospitalier Universitaire de SherbrookeSherbrooke, Quebec
Canada
Contactez l'équipe d'étude
University of Calgary
University of CalgaryCalgary, Alberta
Canada
Contactez l'équipe d'étude
- Étude parrainée par
- Ottawa Heart Institute Research Corporation
- Participants recherchés
- Plus d'informations
- ID de l'étude:
NCT02168829